Who is sponsoring NCT00628576?

NCT00628576 is sponsored by Aalborg University Hospital.

What drugs are being tested in NCT00628576?

Interventions in NCT00628576: unfractionated heparin, Tinzaparin (Leo).

What condition does NCT00628576 study?

NCT00628576 studies Deep Venous Thrombosis.

Is NCT00628576 still recruiting?

NCT00628576 is currently completed. Last updated 26 February 2008.

Last reviewed 2008-02-26 · How we verify

NCT00628576

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Deep Venous Thrombosis. Long-Term Results After Treatment With Either Low-Molecular -Weight Heparin or Unfractionated Heparin. Examinations of the Venous System.

Completed Phase 3 Last updated 26 February 2008

What this trial tests

Phase 3 trial testing unfractionated heparin in Deep Venous Thrombosis in 99 participants. Completed in 1 June 2004.

Timeline

1 October 1993

Primary endpoint
1 June 2004

1 June 2004

Quick facts

Lead sponsor	Aalborg University Hospital
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	99
Start date	1 October 1993
Primary completion	1 June 2004
Estimated completion	1 June 2004
Sites	1 location across Denmark

Drugs / interventions tested

unfractionated heparin — full drug profile →
Tinzaparin (Leo) — full drug profile →

Conditions studied

Deep Venous Thrombosis — all drugs for Deep Venous Thrombosis →

Sponsor

Aalborg University Hospital

Who can join

18 and older, any sex, with Deep Venous Thrombosis. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Clinical evaluation of chronic venous insufficiency (CVI) - (Postthrombotic Syndrome) based on internationally accepted criteria.
Time frame: Two years and 6 to 10 years

Sponsor's own description

The purpose of the study was to evaluate efficacy and safety of the new acute treatment of deep venous thrombosis by use of low-molecular-weight heparin compared with standard treatment using unfractionated heparin, especially concerning long-term morbidity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of unfractionated heparin

Trials testing the same drug.

NCT06275555 — Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation · NA · recruiting
NCT05191290 — Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation · Phase 4 · completed
NCT04925167 — Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO · NA · completed
NCT04528888 — Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection · Phase 3 · unknown
NCT01962116 — Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU · Phase 3 · completed

Other recruiting trials for Deep Venous Thrombosis

Currently open trials in the same condition.

NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT06913595 — Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery · Phase 1 · active not recruiting
NCT05701917 — DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis · NA · recruiting
NCT04924322 — Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies · Phase 2, PHASE3 · recruiting

Other Aalborg University Hospital trials

Trials by the same sponsor.

NCT06960005 — ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease · NA · enrolling by invitation
NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
NCT07185958 — Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy · not yet recruiting
NCT07165574 — Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration · not yet recruiting
NCT07173413 — Assessing the Quality of Telephone Follow-Up After Spine Surgery · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00628576 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aalborg University Hospital
Last refreshed: 26 February 2008

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00628576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing